// App-Quantinova.ai

TCT-636 : Impact of Diabetes on the Outcomes in Patients Undergoing Contemporary Percutaneous Coronary Intervention: Analysis From the GLOBAL LEADERS Study

Researchers

Presenter

  • Ply Chichareon

Principal Investigators

  • Norihiro Kogame

  • Kuniaki Takahashi

  • Chun-Chin Chang

  • Mariusz Tomaniak

  • Christopher Raffel

  • Roberto Botelho

  • Eric Eeckhout

  • Sjoerd H. Hofma

  • Diana Trendafilova

  • Zsolt Koszegi

  • Andres Iniguez

  • Joanna Wykrzykowska

  • Jan Piek

  • Scot Garg

  • Christian Hamm

  • Peter Juni

  • Marco Valgimigli

  • Stephan Windecker

  • Yoshinobu Onuma

  • Patrick Serruys

Medical Centers

  • Department of Cardiology, Medisch Centrum Leeuwarden, Leeuwarden, Netherlands

  • Imperial College, London, United Kingdom

  • Triangulo Heart Institute, Uberlândia, Minas Gerais, Brazil

  • Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland

  • University of Toronto, TORONTO, Ontario, Canada.

  • Amsterdam University Medical Centers, Amsterdam Medical Center, Amsterdam, the Netherlands

  • Thorax Center, Erasmus MC, Department of Interventional Cardiology, Rotterdam, Netherlands, Medical University of Warsaw, First Department of Cardiology, Warsaw, Poland

  • Academic Medical Center, Amsterdam, Netherlands

  • East Lancashire Hospitals NHS Trust, Blackburn, United Kingdom

  • Hospital Alvaro Cunqueiro, University Hospital of Vigo, Vigo, Spain

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • UH St. Ekaterina Sofia, Sofia, Bulgaria

  • The Prince Charles Hospital, Brisbane, Queensland, Australia

  • Lausanne University Hospital, Lausanne, Switzerland

  • Kerckhoff Clinic, Bad Nauheim, Germany

  • Swiss Cardiovascular Center, Inselpsital, Bern, Switzerland

  • Department of Cardiology, Josa Andras University Teaching Hospital, Nyiregyhaza, Hungary

Locations

  • Netherlands

  • Switzerland

  • Bulgaria

  • Spain

  • United Kingdom

  • Germany

  • Hungary

  • Australia

  • Poland

  • Canada

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final